PATENT CLAIM ANALYSIS

Application Number: 16164929
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "064000"]

Abstract:
A beta-lactamase inhibitor having a formula (I). Also provided is a method of using the beta-lactamase inhibitor for prevention or treatment of diseases.

Claim (Index 1):
A compound of formula (I): wherein:\n m is 0, 1 or 2; \n n is 0 or 1; \n Y is \u2014C 5 H 3 N\u2014; and \n R 1 , R 2  at each occurrence are hydrogen, amino, \u2014C\u2550NH(NH 2 ), hydroxyl, halogen carboxyl, cyano, thiol, C 1 -C 5  alkyl, C 1 -C 5  alkoxy, C 1 -C 5  alkenyl, C 3 -C 6  cycloalkyl, C 3 -C 6  heterocyclic, thioether, or sulfone.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15162395', '15675253', '15435097', '14773717', '15922376']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7774260351622918
- 35 USC 102 Novelty (BERT): 0.4997886260641912
- Combined Prediction Score: 0.7496622942524818
- Mean Citation Score: 235.779214
- Max Citation Score: 238.2742
- Similarity Product: 169.8033394413948

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test